Massachusetts Life Sciences Center awards $25 million in tax incentives aimed at spurring job creation in the Commonwealth's medical device, biotech and pharmaceutical industries.

The Massachusetts Life Science Center has doled out more than $25 million to 25 life science companies who pledged to create new jobs in its latest round of tax incentives,
Biogen Idec, with a pledge to create 225 new jobs based netted $5.5 million in incentives. Also top on the pledge list was Nova BioMedical, which brought home $1.7 million with a promise of 75 jobs, PerkinElmer with $1.5 million for 60 jobs and Boston Heart Diagnostics with $450,000 for 35 jobs.
According to the rules of the incentives program, these jobs all have to last a minimum of 5 years, and companies can be forced to return the incentives if they can't meet their pledge. The program is run by the Massachusetts Life Sciences Center and the Department of Revenue. The Life Sciences Center is charged with overseeing the Commonwealth's 10-year, $1 billion Life Science Initiative.
In 2013, the annual $25 million in incentives squeezed out a commitment of more than 1,000 new jobs and more than 100 additional pledges than 2012.
The American Orthotic and Prosthetic Assn. sues Medicare and the U.S. Health & Human Services...
Pluristem is seeking clinical proof that stem cell therapy can benefit patients with chronic...
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-...
The FDA approves a novel combat-ready clamp to treat wounds most commonly associated with roadside or...